Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Reperfusion Injury | 30 | 2016 | 1043 | 5.570 |
Why?
|
Hindlimb | 22 | 2015 | 513 | 2.930 |
Why?
|
Ischemia | 19 | 2016 | 1905 | 2.140 |
Why?
|
Phenanthrenes | 8 | 2010 | 65 | 1.980 |
Why?
|
Muscle, Skeletal | 21 | 2016 | 4968 | 1.720 |
Why?
|
Aorta, Thoracic | 7 | 2016 | 1110 | 1.320 |
Why?
|
Pyruvates | 2 | 2016 | 84 | 0.900 |
Why?
|
Spinal Cord Ischemia | 2 | 2016 | 94 | 0.820 |
Why?
|
Paralysis | 2 | 2016 | 250 | 0.800 |
Why?
|
Health Level Seven | 1 | 2021 | 35 | 0.750 |
Why?
|
Muscle, Smooth, Vascular | 7 | 2016 | 1493 | 0.740 |
Why?
|
Vascular Surgical Procedures | 8 | 2014 | 1506 | 0.730 |
Why?
|
Lower Extremity | 6 | 2019 | 1217 | 0.730 |
Why?
|
Adenosine Triphosphate | 9 | 2015 | 2001 | 0.680 |
Why?
|
Spinal Cord | 4 | 2016 | 1811 | 0.670 |
Why?
|
Databases, Genetic | 2 | 2023 | 1758 | 0.620 |
Why?
|
Endothelium, Vascular | 11 | 2013 | 4424 | 0.600 |
Why?
|
Neutrophils | 4 | 2015 | 3779 | 0.580 |
Why?
|
Blood Vessel Prosthesis Implantation | 7 | 2016 | 1456 | 0.540 |
Why?
|
Reperfusion | 3 | 2007 | 268 | 0.540 |
Why?
|
Military Medicine | 2 | 2011 | 185 | 0.530 |
Why?
|
Disease Models, Animal | 22 | 2018 | 18330 | 0.530 |
Why?
|
Genetic Variation | 2 | 2023 | 6611 | 0.530 |
Why?
|
Leukocyte Reduction Procedures | 1 | 2015 | 13 | 0.520 |
Why?
|
Myelitis | 1 | 2016 | 49 | 0.520 |
Why?
|
Aortic Aneurysm, Abdominal | 6 | 2013 | 1250 | 0.510 |
Why?
|
Mitochondria, Muscle | 2 | 2015 | 171 | 0.510 |
Why?
|
Physical Conditioning, Animal | 2 | 2016 | 363 | 0.500 |
Why?
|
Apolipoproteins E | 3 | 2013 | 1459 | 0.490 |
Why?
|
Deoxyribonuclease I | 1 | 2015 | 228 | 0.480 |
Why?
|
Peripheral Vascular Diseases | 7 | 2019 | 488 | 0.470 |
Why?
|
Varicose Veins | 2 | 2016 | 158 | 0.450 |
Why?
|
Regional Blood Flow | 8 | 2016 | 1479 | 0.450 |
Why?
|
Peroxidase | 6 | 2016 | 610 | 0.450 |
Why?
|
Regeneration | 4 | 2017 | 1523 | 0.430 |
Why?
|
Tourniquets | 4 | 2008 | 111 | 0.430 |
Why?
|
Carotid Arteries | 4 | 2016 | 934 | 0.420 |
Why?
|
Mice, Inbred C57BL | 17 | 2016 | 22361 | 0.410 |
Why?
|
Terminology as Topic | 1 | 2020 | 1540 | 0.410 |
Why?
|
Apolipoproteins B | 1 | 2014 | 385 | 0.400 |
Why?
|
Photochemotherapy | 6 | 2018 | 828 | 0.390 |
Why?
|
Cytokines | 6 | 2016 | 7446 | 0.390 |
Why?
|
Endovascular Procedures | 4 | 2015 | 2215 | 0.380 |
Why?
|
Language | 1 | 2021 | 1550 | 0.380 |
Why?
|
Arteriovenous Fistula | 2 | 2018 | 320 | 0.370 |
Why?
|
Vascular System Injuries | 2 | 2011 | 247 | 0.370 |
Why?
|
Cell Transplantation | 1 | 2013 | 475 | 0.360 |
Why?
|
Femoral Artery | 8 | 2016 | 827 | 0.360 |
Why?
|
Animals | 55 | 2018 | 168965 | 0.360 |
Why?
|
Aortic Diseases | 2 | 2015 | 741 | 0.350 |
Why?
|
Antithrombin III | 4 | 2015 | 128 | 0.350 |
Why?
|
Thrombosis | 5 | 2015 | 2954 | 0.340 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 956 | 0.340 |
Why?
|
Models, Genetic | 1 | 2020 | 3445 | 0.340 |
Why?
|
Chemokines, CXC | 3 | 2007 | 420 | 0.330 |
Why?
|
Chemokine CXCL2 | 4 | 2013 | 105 | 0.330 |
Why?
|
Toll-Like Receptor 4 | 1 | 2013 | 588 | 0.330 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.330 |
Why?
|
Interleukin-8 | 2 | 2016 | 704 | 0.330 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2016 | 701 | 0.330 |
Why?
|
Aorta | 4 | 2015 | 2045 | 0.320 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1312 | 0.320 |
Why?
|
Cyclooxygenase 2 | 2 | 2009 | 597 | 0.320 |
Why?
|
Mice | 31 | 2016 | 81912 | 0.320 |
Why?
|
Mice, Inbred Strains | 6 | 2009 | 1765 | 0.320 |
Why?
|
Interleukin-6 | 7 | 2016 | 3227 | 0.310 |
Why?
|
Aorta, Abdominal | 3 | 2011 | 627 | 0.310 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1121 | 0.310 |
Why?
|
Carbon Monoxide | 1 | 2012 | 559 | 0.310 |
Why?
|
Obesity | 3 | 2016 | 13085 | 0.310 |
Why?
|
Androstadienes | 2 | 2020 | 348 | 0.300 |
Why?
|
Poly Adenosine Diphosphate Ribose | 2 | 2005 | 51 | 0.300 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2006 | 428 | 0.290 |
Why?
|
Diphosphonates | 1 | 2012 | 633 | 0.290 |
Why?
|
Thrombophlebitis | 1 | 2008 | 289 | 0.290 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 7 | 2016 | 3804 | 0.290 |
Why?
|
Peptide Hydrolases | 4 | 2015 | 610 | 0.290 |
Why?
|
Extracellular Matrix | 6 | 2017 | 1733 | 0.290 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 872 | 0.290 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2015 | 707 | 0.290 |
Why?
|
Venous Insufficiency | 1 | 2008 | 109 | 0.280 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1804 | 0.280 |
Why?
|
Wounds, Gunshot | 2 | 2009 | 586 | 0.270 |
Why?
|
Laser-Doppler Flowmetry | 6 | 2012 | 236 | 0.270 |
Why?
|
Edema | 2 | 2008 | 764 | 0.270 |
Why?
|
Inflammation | 6 | 2016 | 10869 | 0.270 |
Why?
|
Imidazoles | 1 | 2012 | 1169 | 0.270 |
Why?
|
Prostaglandins | 4 | 2001 | 398 | 0.260 |
Why?
|
Stents | 4 | 2015 | 3193 | 0.260 |
Why?
|
Oxygen | 8 | 2019 | 4252 | 0.260 |
Why?
|
Endothelial Cells | 3 | 2016 | 3582 | 0.250 |
Why?
|
Monokines | 1 | 2005 | 71 | 0.250 |
Why?
|
Enoxaparin | 1 | 2008 | 391 | 0.250 |
Why?
|
Tunica Intima | 3 | 2018 | 455 | 0.250 |
Why?
|
Bone Density Conservation Agents | 1 | 2012 | 797 | 0.240 |
Why?
|
Hypothermia, Induced | 1 | 2010 | 754 | 0.240 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2018 | 291 | 0.230 |
Why?
|
Photosensitizing Agents | 4 | 2018 | 627 | 0.230 |
Why?
|
Alprostadil | 1 | 2004 | 86 | 0.230 |
Why?
|
Iliac Artery | 3 | 2015 | 344 | 0.230 |
Why?
|
Chemokine CXCL1 | 3 | 2010 | 102 | 0.230 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 4 | 2004 | 319 | 0.230 |
Why?
|
Surgery Department, Hospital | 1 | 2005 | 170 | 0.220 |
Why?
|
Time Factors | 24 | 2020 | 40154 | 0.210 |
Why?
|
RNA | 1 | 2013 | 2715 | 0.210 |
Why?
|
DNA | 2 | 2014 | 7210 | 0.210 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2012 | 590 | 0.200 |
Why?
|
Plaque, Atherosclerotic | 1 | 2014 | 1549 | 0.200 |
Why?
|
Spinal Cord Diseases | 1 | 2005 | 291 | 0.190 |
Why?
|
Cells, Cultured | 18 | 2016 | 18989 | 0.190 |
Why?
|
Receptors, Prostaglandin E | 1 | 2001 | 56 | 0.190 |
Why?
|
Inflammation Mediators | 3 | 2016 | 1889 | 0.190 |
Why?
|
Intermittent Claudication | 4 | 2010 | 305 | 0.190 |
Why?
|
Hypercholesterolemia | 1 | 2008 | 1144 | 0.190 |
Why?
|
Cell Hypoxia | 4 | 1999 | 661 | 0.180 |
Why?
|
Male | 57 | 2020 | 364203 | 0.180 |
Why?
|
Mitochondria | 3 | 2009 | 3678 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2006 | 621 | 0.180 |
Why?
|
Logical Observation Identifiers Names and Codes | 1 | 2020 | 16 | 0.180 |
Why?
|
Systematized Nomenclature of Medicine | 1 | 2020 | 35 | 0.180 |
Why?
|
Saphenous Vein | 3 | 2016 | 519 | 0.180 |
Why?
|
RNA, Messenger | 8 | 2009 | 12793 | 0.180 |
Why?
|
Dinoprost | 2 | 1999 | 139 | 0.170 |
Why?
|
Chlorobenzenes | 1 | 2020 | 31 | 0.170 |
Why?
|
Benzyl Alcohols | 1 | 2020 | 33 | 0.170 |
Why?
|
Professional Practice Location | 1 | 2020 | 57 | 0.170 |
Why?
|
Arachidonic Acid | 4 | 1997 | 430 | 0.160 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11063 | 0.160 |
Why?
|
Angioplasty, Balloon | 3 | 2009 | 592 | 0.160 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 109 | 0.160 |
Why?
|
Wound Healing | 3 | 2017 | 2800 | 0.160 |
Why?
|
Macrophages | 1 | 2014 | 5785 | 0.160 |
Why?
|
Limb Salvage | 3 | 2018 | 488 | 0.160 |
Why?
|
Blood Substitutes | 1 | 2019 | 57 | 0.160 |
Why?
|
Rose Bengal | 2 | 2016 | 115 | 0.160 |
Why?
|
Carbamates | 1 | 2020 | 191 | 0.150 |
Why?
|
Genome, Human | 2 | 2023 | 4441 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 3 | 2009 | 743 | 0.150 |
Why?
|
Leg | 4 | 2018 | 1087 | 0.150 |
Why?
|
Penis | 4 | 2002 | 209 | 0.150 |
Why?
|
Neointima | 2 | 2016 | 133 | 0.150 |
Why?
|
Schools, Medical | 1 | 2005 | 883 | 0.150 |
Why?
|
Oxyhemoglobins | 1 | 2019 | 213 | 0.150 |
Why?
|
Administration, Inhalation | 3 | 2020 | 1154 | 0.150 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 3043 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2815 | 0.140 |
Why?
|
Popliteal Artery | 3 | 2009 | 313 | 0.140 |
Why?
|
Muscle, Smooth | 1 | 2001 | 930 | 0.140 |
Why?
|
Vasoconstriction | 2 | 2019 | 591 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2016 | 12250 | 0.140 |
Why?
|
Atherosclerosis | 1 | 2013 | 3418 | 0.140 |
Why?
|
Tissue Survival | 2 | 2009 | 120 | 0.140 |
Why?
|
Constriction | 1 | 2016 | 168 | 0.140 |
Why?
|
Anticoagulants | 3 | 2014 | 4854 | 0.130 |
Why?
|
Liver | 2 | 2010 | 7578 | 0.130 |
Why?
|
Quinolones | 1 | 2020 | 389 | 0.130 |
Why?
|
Venous Pressure | 1 | 2016 | 55 | 0.130 |
Why?
|
Neonatal Screening | 1 | 2021 | 620 | 0.130 |
Why?
|
Electroporation | 1 | 2017 | 238 | 0.130 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 3253 | 0.130 |
Why?
|
Endarterectomy, Carotid | 3 | 2006 | 556 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 2457 | 0.130 |
Why?
|
Kidney Diseases | 2 | 2010 | 2099 | 0.130 |
Why?
|
Reactive Oxygen Species | 4 | 2013 | 2144 | 0.120 |
Why?
|
Humans | 62 | 2024 | 767040 | 0.120 |
Why?
|
Cell Survival | 5 | 2010 | 5750 | 0.120 |
Why?
|
Brachial Artery | 3 | 2007 | 373 | 0.120 |
Why?
|
Cell Proliferation | 4 | 2016 | 10455 | 0.120 |
Why?
|
Microcirculation | 4 | 2010 | 1282 | 0.120 |
Why?
|
Popliteal Vein | 1 | 2014 | 43 | 0.120 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2013 | 5 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 2 | 2016 | 832 | 0.110 |
Why?
|
Lactates | 2 | 2011 | 398 | 0.110 |
Why?
|
Lung | 3 | 2020 | 10076 | 0.110 |
Why?
|
Carotid Stenosis | 3 | 2006 | 858 | 0.110 |
Why?
|
Rejuvenation | 1 | 2015 | 109 | 0.110 |
Why?
|
Cytochrome b Group | 1 | 2013 | 59 | 0.110 |
Why?
|
Aortic Rupture | 2 | 2015 | 322 | 0.110 |
Why?
|
Choice Behavior | 1 | 2020 | 848 | 0.110 |
Why?
|
Hyperplasia | 5 | 2018 | 1150 | 0.110 |
Why?
|
Anastomotic Leak | 1 | 2015 | 170 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2013 | 3511 | 0.110 |
Why?
|
Mice, Knockout | 6 | 2016 | 14476 | 0.110 |
Why?
|
Syndecan-4 | 2 | 2012 | 45 | 0.110 |
Why?
|
Cosmetic Techniques | 1 | 2015 | 149 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2012 | 6215 | 0.100 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.100 |
Why?
|
Cross-Linking Reagents | 1 | 2016 | 689 | 0.100 |
Why?
|
Capillaries | 1 | 2016 | 755 | 0.100 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2012 | 51 | 0.100 |
Why?
|
Postoperative Complications | 9 | 2016 | 15824 | 0.100 |
Why?
|
Protein Prenylation | 1 | 2012 | 70 | 0.100 |
Why?
|
Aortic Coarctation | 1 | 2015 | 278 | 0.100 |
Why?
|
Carotid Artery, Common | 1 | 2013 | 172 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5363 | 0.100 |
Why?
|
Blood Vessel Prosthesis | 4 | 2003 | 956 | 0.100 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2013 | 175 | 0.100 |
Why?
|
Epoprostenol | 5 | 1997 | 246 | 0.100 |
Why?
|
Vena Cava Filters | 2 | 2012 | 270 | 0.100 |
Why?
|
Cattle | 6 | 1997 | 3813 | 0.100 |
Why?
|
Epidermis | 1 | 2015 | 539 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 872 | 0.100 |
Why?
|
Proteolipids | 1 | 2012 | 109 | 0.100 |
Why?
|
Ligation | 2 | 2010 | 446 | 0.100 |
Why?
|
Kidney | 4 | 2010 | 7063 | 0.100 |
Why?
|
Veins | 1 | 2016 | 769 | 0.100 |
Why?
|
Myxoma | 1 | 1992 | 114 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1150 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3683 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2010 | 1374 | 0.090 |
Why?
|
Aneurysm | 1 | 2014 | 343 | 0.090 |
Why?
|
Deoxyribonucleases | 1 | 2012 | 209 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 383 | 0.090 |
Why?
|
Cell Movement | 3 | 2012 | 5203 | 0.090 |
Why?
|
Extremities | 1 | 2016 | 870 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 6 | 2018 | 8108 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1883 | 0.090 |
Why?
|
Anterior Horn Cells | 1 | 2010 | 17 | 0.090 |
Why?
|
Liver, Artificial | 1 | 2010 | 55 | 0.090 |
Why?
|
Dinoprostone | 3 | 2004 | 597 | 0.090 |
Why?
|
Paraplegia | 1 | 2011 | 161 | 0.090 |
Why?
|
Poloxamer | 1 | 2010 | 56 | 0.090 |
Why?
|
Ion Channels | 1 | 2015 | 1043 | 0.090 |
Why?
|
Hyperemia | 2 | 2010 | 223 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2019 | 2140 | 0.080 |
Why?
|
Hemostatic Techniques | 1 | 2011 | 116 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1733 | 0.080 |
Why?
|
Surface-Active Agents | 1 | 2010 | 150 | 0.080 |
Why?
|
Renal Dialysis | 3 | 2016 | 1790 | 0.080 |
Why?
|
Heme Oxygenase-1 | 1 | 2012 | 364 | 0.080 |
Why?
|
Anemia | 1 | 2019 | 1514 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1492 | 0.080 |
Why?
|
Biomedical Research | 1 | 2005 | 3464 | 0.080 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 980 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 635 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2016 | 5891 | 0.080 |
Why?
|
Muscle Contraction | 1 | 2014 | 1208 | 0.080 |
Why?
|
Buttocks | 1 | 2009 | 111 | 0.080 |
Why?
|
Alleles | 1 | 2020 | 6893 | 0.080 |
Why?
|
Myogenin | 1 | 2008 | 54 | 0.080 |
Why?
|
Female | 38 | 2020 | 396660 | 0.080 |
Why?
|
Mutation | 1 | 2013 | 30211 | 0.080 |
Why?
|
Skin | 2 | 2017 | 4499 | 0.080 |
Why?
|
Heart Neoplasms | 1 | 1992 | 374 | 0.080 |
Why?
|
Actins | 1 | 2015 | 2059 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2011 | 1995 | 0.070 |
Why?
|
Renal Artery Obstruction | 2 | 2012 | 216 | 0.070 |
Why?
|
Adipocytes | 1 | 2015 | 1197 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 594 | 0.070 |
Why?
|
MyoD Protein | 1 | 2008 | 143 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1969 | 0.070 |
Why?
|
Internet | 1 | 2020 | 3114 | 0.070 |
Why?
|
Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
Craniocerebral Trauma | 1 | 1992 | 493 | 0.070 |
Why?
|
Treatment Outcome | 17 | 2020 | 65295 | 0.070 |
Why?
|
Subclavian Artery | 1 | 1988 | 138 | 0.070 |
Why?
|
Receptors, CCR2 | 1 | 2008 | 215 | 0.070 |
Why?
|
Physical Exertion | 1 | 2010 | 667 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2012 | 3093 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1347 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2010 | 913 | 0.070 |
Why?
|
Interleukin-1 | 1 | 2011 | 1252 | 0.070 |
Why?
|
Locomotion | 1 | 2009 | 388 | 0.070 |
Why?
|
Trans-Activators | 1 | 2016 | 2856 | 0.070 |
Why?
|
Bone Density | 1 | 2020 | 3573 | 0.070 |
Why?
|
Vascular Patency | 3 | 2016 | 915 | 0.070 |
Why?
|
Health Resources | 1 | 2013 | 948 | 0.070 |
Why?
|
Osteopontin | 1 | 2008 | 305 | 0.070 |
Why?
|
Cytoskeletal Proteins | 1 | 2012 | 1326 | 0.070 |
Why?
|
Tail | 1 | 2006 | 91 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2014 | 1407 | 0.070 |
Why?
|
Disease Progression | 2 | 2014 | 13646 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3467 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1377 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6507 | 0.060 |
Why?
|
Graft Occlusion, Vascular | 1 | 2009 | 538 | 0.060 |
Why?
|
Ultrasonography, Doppler, Pulsed | 2 | 2003 | 19 | 0.060 |
Why?
|
Heart Failure | 3 | 2013 | 11877 | 0.060 |
Why?
|
Chemokines | 1 | 2010 | 963 | 0.060 |
Why?
|
Forecasting | 1 | 2015 | 2936 | 0.060 |
Why?
|
Thoracic Arteries | 1 | 2005 | 40 | 0.060 |
Why?
|
Suture Techniques | 1 | 2011 | 775 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 605 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3414 | 0.060 |
Why?
|
Software | 1 | 2020 | 4472 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 2979 | 0.060 |
Why?
|
Patient Selection | 4 | 2016 | 4256 | 0.060 |
Why?
|
Groin | 1 | 2005 | 106 | 0.060 |
Why?
|
Receptors, Leptin | 1 | 2007 | 352 | 0.060 |
Why?
|
Aged | 29 | 2020 | 171319 | 0.060 |
Why?
|
Superoxide Dismutase | 2 | 1999 | 596 | 0.060 |
Why?
|
Binding Sites | 1 | 2014 | 6014 | 0.060 |
Why?
|
Microfluidics | 1 | 2010 | 650 | 0.060 |
Why?
|
Phosphorylation | 1 | 2016 | 8310 | 0.060 |
Why?
|
Lactic Acid | 2 | 2004 | 1139 | 0.060 |
Why?
|
Arm | 1 | 1988 | 591 | 0.060 |
Why?
|
Risk Assessment | 6 | 2019 | 24299 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4114 | 0.060 |
Why?
|
Lipocalins | 1 | 2005 | 160 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2016 | 3986 | 0.060 |
Why?
|
Cholesterol | 2 | 2008 | 2905 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 969 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 411 | 0.060 |
Why?
|
Aged, 80 and over | 14 | 2019 | 59548 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4627 | 0.060 |
Why?
|
Cell Count | 3 | 1996 | 1825 | 0.060 |
Why?
|
Acute-Phase Proteins | 1 | 2005 | 251 | 0.060 |
Why?
|
Cyclooxygenase 1 | 1 | 2004 | 98 | 0.060 |
Why?
|
Fibrinolysis | 1 | 2005 | 331 | 0.060 |
Why?
|
Middle Aged | 25 | 2020 | 223233 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1721 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4881 | 0.050 |
Why?
|
Drug Combinations | 2 | 2020 | 2086 | 0.050 |
Why?
|
Renal Insufficiency | 2 | 2013 | 812 | 0.050 |
Why?
|
Durable Medical Equipment | 1 | 2003 | 23 | 0.050 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2005 | 425 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15925 | 0.050 |
Why?
|
Hepatocytes | 1 | 2010 | 1247 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2495 | 0.050 |
Why?
|
Angioplasty | 1 | 2006 | 355 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2012 | 2054 | 0.050 |
Why?
|
Hernia | 1 | 2003 | 67 | 0.050 |
Why?
|
Receptors, Prostaglandin | 1 | 2002 | 53 | 0.050 |
Why?
|
Materials Testing | 1 | 2006 | 870 | 0.050 |
Why?
|
Risk Factors | 13 | 2019 | 74886 | 0.050 |
Why?
|
Equipment Design | 2 | 2011 | 3489 | 0.050 |
Why?
|
NAD | 1 | 2006 | 618 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2079 | 0.050 |
Why?
|
Umbilical Arteries | 2 | 1999 | 77 | 0.050 |
Why?
|
Renal Artery | 1 | 2004 | 355 | 0.050 |
Why?
|
Survivors | 1 | 2013 | 2381 | 0.050 |
Why?
|
Catalase | 2 | 1999 | 215 | 0.050 |
Why?
|
Peripheral Arterial Disease | 1 | 2013 | 1304 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2016 | 20169 | 0.050 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 1697 | 0.050 |
Why?
|
Odds Ratio | 5 | 2016 | 9660 | 0.050 |
Why?
|
Hemorrhage | 2 | 2011 | 3464 | 0.050 |
Why?
|
Surgical Wound Dehiscence | 1 | 2003 | 215 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6602 | 0.050 |
Why?
|
Rats | 5 | 2018 | 23713 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2597 | 0.050 |
Why?
|
Lipids | 2 | 2005 | 3322 | 0.050 |
Why?
|
Proportional Hazards Models | 7 | 2013 | 12536 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6513 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.050 |
Why?
|
Oncogene Proteins | 1 | 2005 | 715 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2004 | 393 | 0.050 |
Why?
|
Heparin | 1 | 2008 | 1636 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3797 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26396 | 0.040 |
Why?
|
Laparotomy | 1 | 2003 | 459 | 0.040 |
Why?
|
Blotting, Western | 1 | 2008 | 5022 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2001 | 168 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9551 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9513 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2006 | 1027 | 0.040 |
Why?
|
Signal Transduction | 3 | 2016 | 23621 | 0.040 |
Why?
|
Vasodilation | 4 | 2007 | 968 | 0.040 |
Why?
|
Motor Neurons | 1 | 2005 | 869 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6067 | 0.040 |
Why?
|
Hernia, Ventral | 1 | 2003 | 220 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1688 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1055 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 2020 | 139 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1883 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2299 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1403 | 0.040 |
Why?
|
Indomethacin | 1 | 1999 | 323 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8048 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 1999 | 213 | 0.040 |
Why?
|
Protozoan Proteins | 1 | 2005 | 843 | 0.040 |
Why?
|
Partial Pressure | 2 | 1997 | 247 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3431 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1999 | 361 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10393 | 0.040 |
Why?
|
COS Cells | 1 | 1999 | 1135 | 0.040 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 249 | 0.040 |
Why?
|
Sympathectomy | 1 | 1998 | 72 | 0.040 |
Why?
|
Foot Ulcer | 1 | 1998 | 62 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 1 | 1997 | 70 | 0.040 |
Why?
|
New York City | 1 | 2020 | 736 | 0.040 |
Why?
|
Cholesterol Esters | 1 | 1997 | 68 | 0.040 |
Why?
|
Glycerides | 1 | 1997 | 67 | 0.030 |
Why?
|
Boston | 3 | 2016 | 9360 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14672 | 0.030 |
Why?
|
History, 20th Century | 1 | 2005 | 2765 | 0.030 |
Why?
|
DNA Damage | 1 | 2006 | 2469 | 0.030 |
Why?
|
Compliance | 1 | 2016 | 100 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1418 | 0.030 |
Why?
|
Reoperation | 3 | 2013 | 4325 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 1999 | 740 | 0.030 |
Why?
|
Databases as Topic | 2 | 2010 | 472 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3726 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2010 | 1646 | 0.030 |
Why?
|
Carbon Radioisotopes | 1 | 1997 | 544 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12451 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2016 | 284 | 0.030 |
Why?
|
Genomics | 1 | 2011 | 5924 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4349 | 0.030 |
Why?
|
Antimetabolites | 1 | 1996 | 128 | 0.030 |
Why?
|
Prospective Studies | 7 | 2020 | 54886 | 0.030 |
Why?
|
Information Dissemination | 1 | 2024 | 1142 | 0.030 |
Why?
|
Thromboxanes | 1 | 1995 | 45 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1997 | 393 | 0.030 |
Why?
|
Comorbidity | 3 | 2016 | 10582 | 0.030 |
Why?
|
Follow-Up Studies | 9 | 2009 | 39317 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2012 | 20741 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 405 | 0.030 |
Why?
|
Age Factors | 4 | 2016 | 18401 | 0.030 |
Why?
|
Recovery of Function | 1 | 2005 | 2978 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2020 | 1830 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 430 | 0.030 |
Why?
|
Electrodes | 1 | 2017 | 612 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22350 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2016 | 163 | 0.030 |
Why?
|
Retrospective Studies | 11 | 2016 | 81659 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2016 | 527 | 0.030 |
Why?
|
Elasticity | 1 | 2016 | 654 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2127 | 0.030 |
Why?
|
Pentoxifylline | 1 | 1994 | 53 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2013 | 17 | 0.030 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2013 | 44 | 0.030 |
Why?
|
Casein Kinase Ialpha | 1 | 2013 | 26 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1995 | 411 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 1729 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12986 | 0.030 |
Why?
|
Culture Media | 1 | 1996 | 892 | 0.030 |
Why?
|
Elastic Tissue | 1 | 2013 | 65 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12069 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9532 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14766 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 149 | 0.030 |
Why?
|
Aspirin | 2 | 1999 | 3135 | 0.030 |
Why?
|
Phospholipids | 1 | 1997 | 778 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3432 | 0.030 |
Why?
|
United States | 5 | 2020 | 72971 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 1999 | 2201 | 0.030 |
Why?
|
Angiography | 2 | 2009 | 1597 | 0.020 |
Why?
|
Hypertension, Renovascular | 1 | 2012 | 115 | 0.020 |
Why?
|
Blood Glucose | 1 | 2007 | 6421 | 0.020 |
Why?
|
Respiration | 1 | 2019 | 1655 | 0.020 |
Why?
|
Recurrence | 3 | 2014 | 8504 | 0.020 |
Why?
|
Cardiovascular Diseases | 3 | 2007 | 15645 | 0.020 |
Why?
|
Proteoglycans | 1 | 1995 | 807 | 0.020 |
Why?
|
Survival Rate | 4 | 2009 | 12823 | 0.020 |
Why?
|
Medical Oncology | 1 | 2024 | 2341 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4855 | 0.020 |
Why?
|
Logistic Models | 3 | 2016 | 13284 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 1997 | 1673 | 0.020 |
Why?
|
Prosthesis Design | 2 | 2012 | 2120 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 1988 | 4713 | 0.020 |
Why?
|
Accidental Falls | 1 | 1999 | 1079 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2006 | 4306 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 331 | 0.020 |
Why?
|
Patient Participation | 1 | 2020 | 1444 | 0.020 |
Why?
|
Ureteral Obstruction | 1 | 2012 | 293 | 0.020 |
Why?
|
Wrist | 1 | 1992 | 231 | 0.020 |
Why?
|
Cell Death | 1 | 1996 | 1677 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1751 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 15567 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 3249 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 1992 | 574 | 0.020 |
Why?
|
Arteries | 2 | 1992 | 1123 | 0.020 |
Why?
|
Ischemic Preconditioning | 1 | 2010 | 89 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18063 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 1197 | 0.020 |
Why?
|
Adult | 10 | 2019 | 223317 | 0.020 |
Why?
|
Punctures | 1 | 2011 | 371 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1994 | 627 | 0.020 |
Why?
|
Kinetics | 1 | 1997 | 6287 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2931 | 0.020 |
Why?
|
Bioreactors | 1 | 2010 | 245 | 0.020 |
Why?
|
Pulmonary Embolism | 2 | 2014 | 2598 | 0.020 |
Why?
|
Heart Diseases | 1 | 2002 | 2817 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36582 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1248 | 0.020 |
Why?
|
Back Pain | 1 | 2012 | 547 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1168 | 0.020 |
Why?
|
Critical Illness | 2 | 2013 | 2753 | 0.020 |
Why?
|
Endothelium | 2 | 1997 | 768 | 0.020 |
Why?
|
Dextrans | 1 | 2010 | 574 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1997 | 1680 | 0.020 |
Why?
|
Cell Division | 3 | 1997 | 4473 | 0.020 |
Why?
|
Radiography | 2 | 2011 | 6975 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2636 | 0.020 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 2 | 1998 | 34 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2519 | 0.020 |
Why?
|
Device Removal | 1 | 2012 | 643 | 0.020 |
Why?
|
Methods | 1 | 2007 | 1065 | 0.020 |
Why?
|
Graft Survival | 2 | 2016 | 3896 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7868 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3427 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22254 | 0.020 |
Why?
|
Muscle Cells | 1 | 2007 | 194 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2836 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5987 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1999 | 2513 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2012 | 1069 | 0.020 |
Why?
|
Head | 1 | 1992 | 926 | 0.020 |
Why?
|
Heart Atria | 1 | 1992 | 1362 | 0.020 |
Why?
|
Hospitals, Private | 1 | 2006 | 67 | 0.020 |
Why?
|
Tibial Arteries | 1 | 2005 | 60 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5753 | 0.020 |
Why?
|
Ultrasonography | 2 | 2010 | 6000 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1996 | 3139 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2829 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1988 | 992 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1988 | 1104 | 0.010 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 198 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5796 | 0.010 |
Why?
|
Organ Culture Techniques | 2 | 1996 | 789 | 0.010 |
Why?
|
Microbial Collagenase | 1 | 1984 | 112 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2920 | 0.010 |
Why?
|
Femur | 1 | 2010 | 1321 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Length of Stay | 2 | 2013 | 6489 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2006 | 395 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2006 | 0.010 |
Why?
|
Disease Management | 1 | 2014 | 2531 | 0.010 |
Why?
|
Hydantoins | 1 | 2002 | 12 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2010 | 1319 | 0.010 |
Why?
|
Serotonin | 1 | 1987 | 1045 | 0.010 |
Why?
|
Organometallic Compounds | 2 | 1997 | 648 | 0.010 |
Why?
|
Monocytes | 1 | 2012 | 2598 | 0.010 |
Why?
|
Anesthesia, Conduction | 1 | 2006 | 264 | 0.010 |
Why?
|
Disease-Free Survival | 2 | 2004 | 6844 | 0.010 |
Why?
|
Adolescent | 4 | 2018 | 89046 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3913 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15424 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2013 | 3114 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 2004 | 683 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6813 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1992 | 4892 | 0.010 |
Why?
|
Hydrazines | 1 | 2002 | 223 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3642 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1997 | 9245 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3530 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8068 | 0.010 |
Why?
|
Rabbits | 2 | 1996 | 4751 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 541 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1988 | 1944 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7848 | 0.010 |
Why?
|
Chronic Disease | 2 | 2009 | 9362 | 0.010 |
Why?
|
Cohort Studies | 3 | 2009 | 41718 | 0.010 |
Why?
|
Cell Separation | 1 | 1984 | 1717 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59980 | 0.010 |
Why?
|
Patient Readmission | 1 | 2013 | 3283 | 0.010 |
Why?
|
Morbidity | 1 | 2004 | 1754 | 0.010 |
Why?
|
Crohn Disease | 1 | 1991 | 2295 | 0.010 |
Why?
|
Indoles | 2 | 1997 | 1836 | 0.010 |
Why?
|
Child | 2 | 2024 | 80771 | 0.010 |
Why?
|
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 1996 | 5 | 0.010 |
Why?
|
Postoperative Period | 1 | 2002 | 1824 | 0.010 |
Why?
|
Hospital Charges | 1 | 1999 | 345 | 0.010 |
Why?
|
Blood Platelets | 1 | 1987 | 2464 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8351 | 0.010 |
Why?
|
Thromboxane A2 | 1 | 1996 | 87 | 0.010 |
Why?
|
Tunica Media | 1 | 1996 | 107 | 0.010 |
Why?
|
Free Radicals | 1 | 1996 | 237 | 0.010 |
Why?
|
Infant | 2 | 2013 | 36485 | 0.010 |
Why?
|
Prognosis | 2 | 2007 | 29963 | 0.010 |
Why?
|
Aluminum | 1 | 1996 | 150 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6001 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1997 | 521 | 0.010 |
Why?
|
Knee | 1 | 1997 | 277 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1999 | 1049 | 0.010 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1997 | 348 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5886 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11657 | 0.010 |
Why?
|
Acetylcholine | 1 | 1996 | 628 | 0.010 |
Why?
|
Luciferases | 1 | 1995 | 713 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14098 | 0.010 |
Why?
|
Necrosis | 1 | 1998 | 1614 | 0.010 |
Why?
|
Age Distribution | 1 | 1999 | 2870 | 0.010 |
Why?
|
Massachusetts | 1 | 2005 | 8890 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 1989 | 0.010 |
Why?
|
Lasers | 1 | 1996 | 951 | 0.010 |
Why?
|
DNA Primers | 1 | 1995 | 2827 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4167 | 0.010 |
Why?
|
Preoperative Care | 1 | 1997 | 2252 | 0.000 |
Why?
|
Walking | 1 | 1994 | 1201 | 0.000 |
Why?
|
Incidence | 1 | 2005 | 21526 | 0.000 |
Why?
|
Exercise Test | 1 | 1994 | 2188 | 0.000 |
Why?
|
Phenotype | 1 | 1984 | 16718 | 0.000 |
Why?
|
Hematoma | 1 | 1991 | 766 | 0.000 |
Why?
|
Colectomy | 1 | 1991 | 696 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1999 | 5345 | 0.000 |
Why?
|
Membrane Glycoproteins | 1 | 1995 | 3702 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12414 | 0.000 |
Why?
|
Stroke | 1 | 2005 | 9746 | 0.000 |
Why?
|
Dogs | 1 | 1987 | 3834 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17608 | 0.000 |
Why?
|
Child, Preschool | 1 | 1999 | 42606 | 0.000 |
Why?
|